← All trials
NCT04840992
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 20, 2021
- Primary completion
- Apr 15, 2022
- Completion date
- Jul 15, 2022
- First posted
- Apr 12, 2021
- Last posted
- Aug 2, 2021
- Enrollment
- 840
- Arms / groups
- 22 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tianjin Cansino Biotechnology IncLead sponsor
- Government of ChinaCollaborator
- Beijing Institute of BiotechnologyCollaborator
- Government of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.